D Amp- M Pharma Peru S.a.c | PRO · 2025 |

| Category | Examples | Key Feature | |----------|----------|--------------| | | Amoxicillin, Losartan, Metformin | High bioavailability | | Hospital Injectables | Ceftriaxone, Ondansetron | Preservative-free | | Dermatologicals | Clotrimazole, Betamethasone | Topical creams/ointments | | Diagnostic Reagents | Glucose strips, rapid tests | CE/FDA-approved sources |

To understand the significance of D&M Pharma Peru S.A.C., one must first understand the structure of the Peruvian pharmaceutical market. The market is broadly divided into two channels: the (hospitals and establishments under the Ministry of Health, EsSalud, and the Armed Forces) and the private sector (pharmacy chains, private clinics, and independent pharmacies). d amp- m pharma peru s.a.c

In , D&M Pharma launched its activities in Peru, officially incorporating as D & M Pharma Peru S.A.C. the following year. Today, the company operates with a team of approximately 32 employees out of its headquarters in the San Isidro district of Lima . Core Business Activities and Portfolio | Category | Examples | Key Feature |

This ensures that products reach pharmacies, hospitals, and clinics without potency loss – a major concern in Peru’s varied climate zones. the following year

While the company does not publicly disclose its full catalog, trade publications and procurement records indicate a focus on: